Dr. Valerie Gorman, MD, FACS, attended the San Antonio Breast Cancer Symposium the week of December 10th to learn about the newest findings and studies in breast cancer research, while also doing a poster board presentation of her own research. The SABCS is an annual conference that gathers the newest information and data breast cancer treatment to help improve treatment for patients worldwide.
Dr. Gorman and the Texas Breast Center summarized the visit to the SABCS in an article, discussing studies that caught her attention, such as presentations on
“molecular studies on circulating tumor cells, more targeted therapies, and many other topics. Together with our oncology colleagues and team members, we’re able to use these to treat our patients in a collaborative, multidisciplinary fashion.”
There were also many studies on variations of chemotherapy on HER2 positive and metastatic breast cancer. Dr. Gorman was most interested in a study done by the University of Florence, which was on a topic that matched her own presentation: Accelerated Partial Breast Irradiation, or APBI. The Florence presentation had performed this same shortened radiotherapy treatment that Dr. Gorman does with her patients after surgery to kill any remaining cancer cells.
However, this study had ten-year results to offer: “The results found that survival rates at the ten-year mark for those who received APBI–as with the five-year mark–matched the survival rate of those who received longer treatments. However, APBI has better cosmetic results and less burn damage.”
Texas Breast Center and Dr. Gorman are thrilled to have these long-term results now to know they can better help their results with their practice of giving APBI. They can offer information and answer any questions patients may have on the subject.